Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2022

View Archived Issues

TMID enzymes as potential antiviral targets for the treatment of HHV infections

Researchers improve cisplatin-induced ototoxicity model

Anti-VISTA HMBD-002 antibody blocks VISTA-induced immunosuppression in preclinical models

Chinese researchers identify new CRBN modulators

Eccogene divulges new GLP-1R agonists

Reaction Biology presents new HDAC inhibitors

Challenge Bioproducts synthesizes new PTGER4 ligands

Customization of regulatory elements in hearing loss gene therapies using AAVAnc80 vectors

Zp Spv 3 K/S describes complement C3 inhibitors

Advanced prostate cancer antibody successful in dogs

Researchers unveil new miRNAs tied to cerebral cavernous angioma

PNV-5032 reduces airflow resistance by 25% in animal test of allergen-induced asthma

Akso and Huadong Medicine sign collaborative agreement for AB-002 in Asia Pacific region

Investigators find a role for miR-206 in intracerebral hemorrhage

JR-14a shows potent neuroprotective effect in stroke models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...